Back to VCYT
GOLDMAN SACHS GROUP INC → VCYT
GOLDMAN SACHS GROUP INC VCYT Position History
Veracyte, Inc. • Healthcare
Quarters held
25
Latest value
$882K
Q2 2026
Peak value
$55.2M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $9.9M |
| Q2 2025 | $30.9M |
| Q2 2025 | $244K |
| Q2 2025 | $320K |
| Q2 2025 | $404K |
| Q3 2025 | $23.1M |
| Q3 2025 | $22.3M |
| Q3 2025 | $347K |
| Q3 2025 | $201K |
| Q4 2025 | $376K |
| Q4 2025 | $209K |
| Q4 2025 | $23.4M |
| Q4 2025 | $26.3M |
| Q4 2025 | $26.3M |
| Q4 2025 | $23.4M |
| Q4 2025 | $209K |
| Q4 2025 | $376K |
| Q1 2026 | $24.9M |
| Q1 2026 | $15.9M |
| Q1 2026 | $320K |
| Q2 2026 | $39.5M |
| Q2 2026 | $55.2M |
| Q2 2026 | $265K |
| Q2 2026 | $615K |
| Q2 2026 | $882K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $882K | 15.0K | — | — |
| Q2 2026 | $615K | 10.5K | — | — |
| Q2 2026 | $265K | 4.5K | — | — |
| Q2 2026 | $55.2M | 940.2K | — | — |
| Q2 2026 | $39.5M | 672.7K | — | — |
| Q1 2026 | $320K | 9.9K | — | — |
| Q1 2026 | $15.9M | 492.5K | — | — |
| Q1 2026 | $24.9M | 773.8K | — | — |
| Q4 2025 | $376K | 8.9K | — | — |
| Q4 2025 | $209K | 5.0K | — | — |
| Q4 2025 | $23.4M | 555.1K | — | — |
| Q4 2025 | $26.3M | 625.4K | — | — |
| Q4 2025 | $26.3M | 625.4K | — | — |
| Q4 2025 | $23.4M | 555.1K | — | — |
| Q4 2025 | $209K | 5.0K | — | — |
| Q4 2025 | $376K | 8.9K | — | — |
| Q3 2025 | $201K | 5.8K | — | — |
| Q3 2025 | $347K | 10.1K | — | — |
| Q3 2025 | $22.3M | 650.8K | — | — |
| Q3 2025 | $23.1M | 673.4K | — | — |
| Q2 2025 | $404K | 14.9K | — | — |
| Q2 2025 | $320K | 11.8K | — | — |
| Q2 2025 | $244K | 9.0K | — | — |
| Q2 2025 | $30.9M | 1.14M | — | — |
| Q2 2025 | $9.9M | 367.9K | — | — |